Evaluation of the analgesic effects of clonidine and fentanyl as an Additive to Intrathecal bupivacaine in patients undergoing cesarean sectio

Phase 1

• Conditions: post-operative pain inPatients undergoing cesarean section; post-operative pain in; Patients undergoing cesarean section; Anaesthesiology - Pain management; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12611000909921
• Lead Sponsor: Qazvin Medical Science University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

patients with American Society of Anesthesiologists(ASA) physical status I and II, undergoing elective cesarean section

Exclusion Criteria

significant coexisting disease such as hepato-renal and cardiovascular disease, any contraindication to regional anesthesia such as local infection or bleeding disorders, allergy to clonidine or fentanyl , long-term opioid use or a history of chronic pain.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time to first requirement of analgesic supplement(analgesic administration was initiated by patient request(verbal rating scale[ VRS]>4)[Time to first requirement of analgesic supplement from the time of injection intrathecal anesthetic solution]